Closed System Drug Transfer Device (CSTD) Market to Reach Revenues of USD 8954.9 million by 2027
Research Reports
Feb 09, 2022
The global closed system drug transfer device (CSTD) market size is poised to expand at 19.10?GR over the forecast period (2018-2025).
The market is driven by the prevalence of cancer cases globally. According to the Canadian Cancer Society in 2017, nearly 206, 200 instances were registered with 80,800 dying from the disease. CSTDs are required for protecting hospital staff from hazardous drugs and ensuring their safety. Furthermore, safety guidelines outlined by regulatory bodies for safe handling practices at hospitals and clinics is predicted to augur well for the closed system drug transfer device (CSTD) market.
The developing countries of India and China offer ample opportunities for the market to expand over the forecast period. Investments by medical equipment manufacturers coupled with medical tourism are likely to elicit massive demand for CSTDs. In addition, a report published by the National Institute for Occupational Safety and Health (NIOSH) in 2015 substantiated the effectiveness of these equipment in containing leaks or spillage of dangerous chemicals.
But high costs of implementing these medical devices can stultify the market growth.
Segmentation Analysis
The closed system drug transfer device (CSTD) market is segmented by type, delivery, and end-user.
By type, barrier-type was the largest shareholder in 2017, while the filtration-type held stood second in the global market. This can be attributed to the use of filtration systems for segregating hazardous materials to ensure the safety of hospital staff. By modes of delivery, closed bag/line access devices accounted for the largest share in the CSTD market (2017). Among end-users, specialty centers held 70.92% market share in 2017. This can be linked to high use of chemotherapy drugs by oncology professionals to treat patients suffering from cancer.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7733
Regional Analysis
Geographically, the closed system drug transfer device (CSTD) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA).
The Americas accounted for the largest market share in 2017 and was followed by Europe, APAC and MEA.
Europe has assumed the second position after the Americas mainly due to the sophisticated healthcare industry. Awareness of the adverse effects of drug exposure which may cause infertility coupled with availability of CSTD products for hospitals can evoke high market demand during the forecast period.
The MEA region is projected to experience a sluggish growth rate due to the underdeveloped healthcare sector and low adoption rate of latest technologies.
Competitive Analysis
Key players in the closed system drug transfer device (CSTD) market include Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (U.S.), Corvida Medical (U.S.), ICU Medical Inc. (U.S.), Yukon Medical (U.S.), and Equashield LLC (U.S.).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/closed-system-drug-transfer-device-market-7733
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Contact us: Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English